eversyn (Accelerator)

Company Description: eversyn, a spin-off from Max Planck Society, pioneers cell-free biosynthesis, advancing beyond precision fermentation. Precision fermentation using cell factories often results in a mixture of many things in the reaction pot with lots of byproducts, making it difficult to achieve high yields for complex health-beneficial glycans (aka. carbohydrates or sugars). While precision fermentation can effectively produce simple compounds with up to 3 linkages, it often struggles with transferring long chains of molecules intact through cell membranes after production. By going cell-free, eversyn can be the first to market in many high-value applications of glycans, including but not limited to complex human milk oligosaccharides and tailored therapeutic protein glycosylation.